RNF13: A novel RING-type ubiquitin ligase over-expressed in pancreatic cancer

Cell Research

Volumn 19, Issue 3, 2009, Pages 348-357

  Zhang, Qiang ^a   Meng, Yunxiao ^a   Zhang, Lei ^a   Chen, Jie ^a   Zhu, Dahai ^a  

^a TSINGHUA UNIVERSITY   (China)

Author keywords

Histological grading; Invasion; Pancreatic cancer; PanINs; RNF13; Ubiquitin ligase

Indexed keywords

GLYCOPROTEIN; MICRORNA; MIRN127 MICRORNA, MOUSE; RNF13 PROTEIN, HUMAN; TENASCIN; UBIQUITIN PROTEIN LIGASE;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CANCER INVASION; CARCINOMA IN SITU; CELL MEMBRANE; CELL PROLIFERATION; CHEMISTRY; CHRONIC PANCREATITIS; ENDOPLASMIC RETICULUM; ENZYMOLOGY; GLYCOSYLATION; GOLGI COMPLEX; HUMAN; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; PANCREAS TUMOR; PATHOLOGY; RING FINGER MOTIF; SEQUENCE ANALYSIS; TUMOR CELL LINE;

ADULT; AGED; AMINO ACID SEQUENCE; CARCINOMA IN SITU; CELL LINE, TUMOR; CELL MEMBRANE; CELL PROLIFERATION; ENDOPLASMIC RETICULUM; GLYCOPROTEINS; GLYCOSYLATION; GOLGI APPARATUS; HUMANS; MICRORNAS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; PANCREATITIS, CHRONIC; RING FINGER DOMAINS; SEQUENCE ANALYSIS, PROTEIN; TENASCIN; UBIQUITIN-PROTEIN LIGASES;

EID: 61849157310     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2008.285     Document Type: Article

References (33)

1. Burger A, Amemiya Y, Kitching R, Seth AK. Novel RING E3 ubiquitin ligases in breast cancer. Neoplasia 2006; 8:689-695.
2. Subramaniam V, Li H, Wong M, et al. The RING-H2 protein RNF 11 is overexpressed in breast cancer and is a target of Smurf2 E3 ligase. Br J Cancer 2003; 89:1538-1544.
3. Kitching R, Wong MJ, Koehler D, et al. The RING-H2 protein RNF 11 is differentially expressed in breast tumours and interacts with HECT-type E3 ligases. Biochim Biophys Acta 2003; 1639:104-112.
4. Burger AM, Gao Y, Amemiya Y, et al. A novel RING-type ubiquitin ligase breast cancer-associated gene 2 correlates with outcome in invasive breast cancer. Cancer Res 2005; 65:10401- 10412.
5. Wan M, Huang J, Jhala NC, et al. SCF(beta-TrCPl) controls Smad4 protein stability in pancreatic cancer cells. Am J Pathol 2005; 166:1379-1392.
6. Calhoun ES, Jones JB, Ashfaq R, et al. BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) mutations in distinct subsets of pancreatic cancer: potential therapeutic targets. Am J Pathol 2003; 163:1255-1260.
7. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin 2007; 57:43-66.
8. Hruban RH, Adsay NV, Albores-Saavedra J, et al. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 2001; 25:579-586.
9. Tranque P, Crossin KL, Cirelli C, Edelman GM, Mauro VP. Identification and characterization of a RING zinc finger gene (C-RZF) expressed in chicken embryo cells. Proc Natl Acad Sci USA 1996; 93:3105-3109.
10. Juuti A, Nordling S, Louhimo J, Lundin J, Haglund C. Tenascin C expression is upregulated in pancreatic cancer and correlates with differentiation. J Clin Pathol 2004; 57:1151 -1155.
11. Jahkola T, Toivonen T, Nordling S, von Smitten K, Virtanen I. Expression of tenascin-C in intraductal carcinoma of human breast: relationship to invasion. Eur J Cancer 1998; 34:1687- 1692.
12. Adams M, Jones JL, Walker RA, Pringle JH, Bell SC. Changes in tenascin-C isoform expression in invasive and preinvasive breast disease. Cancer Res 2002; 62:3289-3297.
13. Leins A, Riva P, Lindstedt R, et al. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma. Cancer 2003; 98:2430-2439.
14. Loukopoulos P, Shibata T, Katoh H, et al. Genome-wide array-based comparative genomic hybridization analysis of pancreatic adenocarcinoma: identification of genetic indicators that predict patient outcome. Cancer Sci 2007; 98:392-400.
15. Mueller DL. E3 ubiquitin ligases as T cell anergy factors. Nat Immunol 2004; 5:883-890.
16. Anandasabapathy N, Ford GS, Bloom D, et al. GRAIL: an E3 ubiquitin ligase that inhibits cytokine gene transcription is expressed in anergic CD4+ T cells. Immunity 2003; 18:535-547.
17. Yamada HY, Gorbsky GJ. Tumor suppressor candidate TSSC5 is regulated by UbcH6 and a novel ubiquitin ligase RING105. Oncogene 2006; 25:1330-1339.
18. Gmachl M, Gieffers C, Podtelejnikov AV, Mann M, Peters JM. The RING-H2 finger protein APC11 and the E2 enzyme UBC4 are sufficient to ubiquitinate substrates of the anaphase-promoting complex. Proc Natl Acad Sci USA 2000; 97:8973-8978.
19. Joazeiro CA, Wing SS, Huang H, et al. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. Science 1999; 286:309-312.
20. Orend G, Chiquet-Ehrismann R. Tenascin-C induced signaling in cancer. Cancer Lett 2006; 244:143-163.
21. Esposito I, Penzel R, Chaib-Harrireche M, et al. Tenascin C and annexin II expression in the process of pancreatic carcinogenesis. J Pathol 2006; 208:673-685.
22. Mahon P, Bateman A. The PA domain: a protease-associated domain. Protein Sci 2000; 9:1930-1934.
23. Luo X, Hofmann K. The protease-associated domain: a homology domain associated with multiple classes of proteases. Trends Biochem Sci 2001; 26:147-148.
24. Joazeiro CA, Weissman AM. RING finger proteins: mediators of ubiquitin ligase activity. Cell 2000; 102:549-552.
25. Asomaning K, Reid AE, Zhou W, et al. MDM2 promoter polymorphism and pancreatic cancer risk and prognosis. Clin Cancer Res 2009,; 14:4010-4015.
26. Ruiz C, Huang W, Hegi ME, et al. Growth promoting signaling by tenascin-C [corrected]. Cancer Res 2004; 64:7377-7385.
27. Fryer BH, Field J. Rho, Rac, Pak and angiogenesis: old roles and newly identified responsibilities in endothelial cells. Cancer Lett 2005; 229:13-23.
28. Zhu L, Shi G, Schmidt CM, Hruban RH, Konieczny SF. Acinar cells contribute to the molecular heterogeneity of pancreatic intraepithelial neoplasia. Am J Pathol 2007; 171:263-273.
29. Zhang L, Sanderson SO, Lloyd RV, Smyrk TC. Pancreatic intraepithelial neoplasia in heterotopic pancreas: evidence for the progression model of pancreatic ductal adenocarcinoma. Am J Surg Pathol 2007; 31:1191 -1195.
30. Hruban RH, Fukushima N. Pancreatic adenocarcinoma: update on the surgical pathology of carcinomas of ductal origin and PanlNs. Mod Pathol 2007; 20:S61-S70.
31. Rosty C, Geradts J, Sato N, et al. pl6 Inactivation in pancreatic intraepithelial neoplasias (PanlNs) arising in patients with chronic pancreatitis. Am J Surg Pathol 2003; 27:1495-1501.
32. Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 2006; 25:9-34.
33. Furukawa M, Ohta T, Xiong Y. Activation of UBC5 ubiquitinconjugating enzyme by the RING finger of ROC1 and assembly of active ubiquitin ligases by all cullins. J Biol Chem 2002; 277:15758-15765.